主要骨内突肉瘤:来自三级癌症中心的经验
Vishnu Ramanujan1, Srikanth Soma1, Chandra Kumar Krishnan1
1Department of Surgical Oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, India.
South Asian journal of cancer
|December 31, 2025
概括
主要骨内突肉瘤 (PISS) 是一种罕见的骨癌. 这项对7例病例的研究发现,无病5年生存率为80%,总生存率为61%,这表明软组织变异的结果与软组织变异相似.
科学领域:
- 整形瘤学 整形瘤学
- 骨病理学 骨病理学 骨病理学
- 骨恶性瘤是什么?
背景情况:
- 初级骨内突肉瘤 (PISS) 是一种非常罕见的骨恶性瘤.
- 有限的病例报告存在,阻碍了标准化的治疗方案.
- 本研究分析了机构数据,以更好地了解PISS特征和预后.
研究的目的:
- 在研究所内评估PISS诊断.
- 为了确定与PISS相关的组织病理学发现.
- 调查影响PISS患者生存的预后因素.
主要方法:
- 对1995年1月至2016年12月期间诊断的七例PISS病例进行了回顾性研究.
- 经过审计的患者人口统计,瘤位置,组织学,外科边缘和治疗方式.
- 分析了影响患者生存的变量.
主要成果:
- 确定了7例PISS病例,主要影响下肢和骨盆.
- 该队列包括5名男性和2名女性,年龄16~46岁 (平均29.6岁).
- 五年无病生存率为80%,整体生存率为61%.
结论:
- PISS是一种罕见的癌症,没有确立的管理准则.
- 对PISS的生存率似乎与软组织突肉瘤的生存率相当.
- 需要进一步的研究来建立最佳的治疗策略.
相关概念视频
Rous Sarcoma Virus (RSV) and Cancer
6.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.1K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancers Originate from Somatic Mutations in a Single Cell
14.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.5K
Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K


